检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李鑫[1] 张鹏飞[1] 韩利江[1] 张俊廷[1] LI Xin ZHANG Pengfei HAN Lijiang ZHANG Junting(Departrnent of Neurosurgery, Bering Tiantan Hospital, Capital Medical University, Beijing 100050, China)
机构地区:[1]首都医科大学附属北京天坛医院神经外科,北京100050
出 处:《中华神经外科疾病研究杂志》2017年第2期146-150,共5页Chinese Journal of Neurosurgical Disease Research
摘 要:目的探讨成人单侧丘脑胶质瘤的临床特点及显微外科治疗。方法总结16例丘脑肿瘤的临床特点,结合肿瘤位置分别采用多种入路切除肿瘤。10例患者术中行弥散张量成像功能核磁导航辅助,15例患者术后早期放化疗。结果肿瘤全切15例(94%),近全切1例(6%)。术后1 w改善患者9例(56%);如故患者7例(44%)。术后失神发作1例,部分运动性失语1例,无手术直接死亡。2例术后脑积水行脑室-腹腔分流术,1例术后张力性积液行立体定向穿刺术。病理15例Ⅲ~Ⅳ级,1例Ⅱ级。随访14~28个月(平均17.9个月),目前除1例未早期放化疗患者复发外,余15例患者中有5例复发,时间为术后3~16个月,平均9.8个月,其中3例已经死亡(存活13~20个月,平均17个月),均为肿瘤复发播散。1年存活率100%,1年无进展生存75.0%,2年存活率81.0%,2年无进展生存62.5%。结论显微外科技术进步结合神经导航技术的发展,使得手术最大范围切除丘脑胶质瘤病残率及死亡率已明显降低,丘脑胶质瘤治疗首选最大范围手术切除,术后应辅以必要的放疗和化疗等综合治疗。Objective The clinical characteristics and microsurgical treatment of adult unilateral thalamic glionka were investigated, Methads The clinical characteristics of 16 cases and the different approaches for surgery were analyzed, respectively. Diffusion Tensor Imaging (DTI) functional magnetic navigation was used in 10 patients. Subsequent chemoradiotherapy was applied in 15 cases post-operatively. Results Total resection of the tumor was achieved in 15 cases (94%) and subtotal resection in 1 case (6%). Post-operative improvement was achieved in 9 cases (56%) and unchanged in 7 cases (44%). Partial motor aphasia occurred in 1 case. Absence seizure occurred in 1 case. There was no surgery-related death. Ventriculoperitoneal shunt was performed in 2 cases of hydrocephalus; stereotactic puncture was performed in 1 case of post-operative tension effusion. The pathological examination confimed 15 cases of Grade Ⅲ - Ⅳ glionkas and 1 case of Grade Ⅱ glioma. Recurrence was occurred in 5 of 15 patients (except 1 case) with subsequent chemoradiotherapy (3 - 16 months, average 9.8 months). Three patients died because of recurrence (survival time: 13 -20 months, average 17 months). Follow-up survival rate of 1 year and 2 years were 100% and 81.0%, respectively. Progression free survival of 1 year and 2 year were 75.0% and 62. 5%, respectively. Conelusion It makes the morbidity and mortality of maximal surgical resection for patients with thalamic gliowa decrease significantly due to the development of microsurgical technique and neuronavigation. It is the best choice for patients with thalamic glioma to perform maximal surgical resection and subsequent chemoradiotherapy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.216.45.231